GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 10,501 shares of the company's stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $60.77, for a total transaction of $638,145.77. Following the completion of the sale, the chief executive officer directly owned 104,372 shares of the company's stock, valued at $6,342,686.44. The trade was a 9.14% decrease in their position. The…